|
|
Volumn 2, Issue 4, 2001, Pages 365-372
|
|
Primary hyperparathyroidism.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
DIAGNOSTIC AGENT;
DIURETIC AGENT;
FUROSEMIDE;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
PARATHYROID HORMONE;
PHOSPHATE;
RADIOPHARMACEUTICAL AGENT;
ADENOCARCINOMA;
ADENOMA;
BLOOD;
COMPUTER ASSISTED SURGERY;
DIAGNOSTIC IMAGING;
FEEDBACK SYSTEM;
FLUID THERAPY;
HUMAN;
HYPERCALCEMIA;
HYPERPARATHYROIDISM;
HYPERPLASIA;
KIDNEY;
METABOLIC BONE DISEASE;
METABOLISM;
METHODOLOGY;
PARATHYROID GLAND;
PARATHYROID TUMOR;
PARATHYROIDECTOMY;
PATHOLOGY;
REVIEW;
SECRETION;
ADENOCARCINOMA;
ADENOMA;
BONE DISEASES, METABOLIC;
CALCITONIN;
DIAGNOSTIC IMAGING;
DIPHOSPHONATES;
DIURETICS;
FEEDBACK;
FLUID THERAPY;
FUROSEMIDE;
HUMANS;
HYPERCALCEMIA;
HYPERPARATHYROIDISM;
HYPERPLASIA;
KIDNEY;
PARATHYROID GLANDS;
PARATHYROID HORMONE;
PARATHYROID NEOPLASMS;
PARATHYROIDECTOMY;
PHOSPHATES;
RADIOPHARMACEUTICALS;
SURGERY, COMPUTER-ASSISTED;
TECHNETIUM TC 99M SESTAMIBI;
|
|
EID: 0035436428
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-001-0030-8 Document Type: Review |
|
Times cited : (13)
|
|
References (25)
|
